Terms: = Gastric cancer AND MSN, P26038, 4478, ENSG00000147065
12 results:
1. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].
Lin X; Huang M; Chen J; Zhou X; Zhong Z; Lu W; Huang X; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1432-1439. PubMed ID: 37712282
[TBL] [Abstract] [Full Text] [Related]
2. Chemical characterization of Brazilian savannah Byrsonima species (muricis) and their impact on genomic instability and chemopreventive effects.
Specian AFL; Tuttis K; Serpeloni JM; Ribeiro DL; Nunes HL; Tangerina MMP; Sannomiya M; Varanda EA; Vilegas W; Cólus IMS
Mutat Res Genet Toxicol Environ Mutagen; 2023 Apr; 887():503586. PubMed ID: 37003647
[TBL] [Abstract] [Full Text] [Related]
3. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer.
Lin M; Yao W; Xiao Y; Dong Z; Huang W; Zhang F; Zhou X; Liang M
Bioengineered; 2021 Dec; 12(1):6343-6353. PubMed ID: 34506231
[TBL] [Abstract] [Full Text] [Related]
4. FBXO50 Enhances the Malignant Behavior of gastric cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract] [Full Text] [Related]
5. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract] [Full Text] [Related]
7. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract] [Full Text] [Related]
8. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract] [Full Text] [Related]
9. Chemical analysis and screening as anticancer agent of anthocyanin-rich extract from Uva Caimarona ( Pourouma cecropiifolia Mart.) fruit.
Barrios J; Cordero CP; Aristizabal F; Heredia FJ; Morales AL; Osorio C
J Agric Food Chem; 2010 Feb; 58(4):2100-10. PubMed ID: 20121190
[TBL] [Abstract] [Full Text] [Related]
10. Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.
Rachamalla R; Malamud S; Grossbard ML; Mathew S; Dietrich M; Kozuch P
Anticancer Drugs; 2004 Mar; 15(3):211-7. PubMed ID: 15014353
[TBL] [Abstract] [Full Text] [Related]
11. A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.
Chen XY; Zhao LM; Zhong DF
Br J Clin Pharmacol; 2003 Jun; 55(6):570-8. PubMed ID: 12814451
[TBL] [Abstract] [Full Text] [Related]
12. A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.
Bailey H; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Grem JL; Spriggs DR
Cancer Chemother Pharmacol; 1992; 30(4):297-302. PubMed ID: 1643698
[TBL] [Abstract] [Full Text] [Related]
